91 related articles for article (PubMed ID: 16340982)
1. Nonsense mutations: running the red light.
Ainsworth C
Nature; 2005 Dec; 438(7069):726-8. PubMed ID: 16340982
[No Abstract] [Full Text] [Related]
2. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
Linde L; Boelz S; Nissim-Rafinia M; Oren YS; Wilschanski M; Yaacov Y; Virgilis D; Neu-Yilik G; Kulozik AE; Kerem E; Kerem B
J Clin Invest; 2007 Mar; 117(3):683-92. PubMed ID: 17290305
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of beta-thalassaemia caused by 22-bp duplication.
Svasti S; Boonchoy C; Vanichsetakul P; Winichagoon P; Fucharoen S
Ann Hematol; 2008 Aug; 87(8):633-7. PubMed ID: 18392622
[TBL] [Abstract][Full Text] [Related]
4. [Features of NMD (nonsense-mediated mRNA decay) in mammalian cells].
Hosoda N
Tanpakushitsu Kakusan Koso; 2006 Dec; 51(16 Suppl):2544-8. PubMed ID: 17471976
[No Abstract] [Full Text] [Related]
5. Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes.
Allamand V; Bidou L; Arakawa M; Floquet C; Shiozuka M; Paturneau-Jouas M; Gartioux C; Butler-Browne GS; Mouly V; Rousset JP; Matsuda R; Ikeda D; Guicheney P
J Gene Med; 2008 Feb; 10(2):217-24. PubMed ID: 18074402
[TBL] [Abstract][Full Text] [Related]
6. Human alpha2-globin nonsense-mediated mRNA decay induced by a novel alpha-thalassaemia frameshift mutation at codon 22.
Pereira FJ; do Céu Silva M; Picanço I; Seixas MT; Ferrão A; Faustino P; Romão L
Br J Haematol; 2006 Apr; 133(1):98-102. PubMed ID: 16512835
[TBL] [Abstract][Full Text] [Related]
7. Detection of a rare beta-globin nonsense mutation [codon 59 (AAG-->TAG)] in an Italian family.
Amato A; Pia Cappabianca M; Ponzini D; Di Biagio P; Colosimo A; Guida V; Mastropietro F; Foglietta E; Grisanti P; Rinaldi S; Dallapiccola B; Bianco I
Hemoglobin; 2006; 30(3):405-7. PubMed ID: 16840234
[TBL] [Abstract][Full Text] [Related]
8. [Nonsense-mediated mRNA decay (NMD)--on guard of mRNA quality].
Dzikiewicz A; Szweykowska-Kulińska Z
Postepy Biochem; 2006; 52(4):390-8. PubMed ID: 17536508
[TBL] [Abstract][Full Text] [Related]
9. Analysis of nonsense-mediated mRNA decay by monitoring mRNA half-lives in mammalian cells.
Yamashita A; Ohno S
Cold Spring Harb Protoc; 2010 Feb; 2010(2):pdb.prot5386. PubMed ID: 20150149
[No Abstract] [Full Text] [Related]
10. The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision?
Silva AL; Romão L
FEBS Lett; 2009 Feb; 583(3):499-505. PubMed ID: 19162024
[TBL] [Abstract][Full Text] [Related]
11. Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges.
Kuzmiak HA; Maquat LE
Trends Mol Med; 2006 Jul; 12(7):306-16. PubMed ID: 16782405
[TBL] [Abstract][Full Text] [Related]
12. Ignoring the nonsense: a phase II trial in cystic fibrosis.
Hyde SC; Gill DR
Lancet; 2008 Aug; 372(9640):691-2. PubMed ID: 18722009
[No Abstract] [Full Text] [Related]
13. Detection of two rare beta-thalassemia alleles found in the Tunisian population: codon 47 (+A) and codons 106/107 (+G).
Bibi A; Messaoud T; Beldjord C; Fattoum S
Hemoglobin; 2006; 30(4):437-47. PubMed ID: 16987798
[TBL] [Abstract][Full Text] [Related]
14. First Spanish case of thalassemia major due to a compound heterozygosity for the IVS-II-848 (C --> A) and codon 39 (C --> T) mutations of the beta-globin gene.
Ropero P; Villegas A; Muñoz J; Briceño O; Mora A; Salvador M; Polo M; González FA
Hemoglobin; 2006; 30(1):15-21. PubMed ID: 16540410
[TBL] [Abstract][Full Text] [Related]
15. Novel human pathological mutations. Gene symbol: CFTR. Disease: cystic fibrosis.
Farra C; Medawar R; Cabet F; Mroueh S; Souaid M; Hourani H; Mounsef C; Ashkar H; Awwad J
Hum Genet; 2007 Dec; 122(5):553. PubMed ID: 18383592
[No Abstract] [Full Text] [Related]
16. The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells.
Linde L; Boelz S; Neu-Yilik G; Kulozik AE; Kerem B
Eur J Hum Genet; 2007 Nov; 15(11):1156-62. PubMed ID: 17625509
[TBL] [Abstract][Full Text] [Related]
17. Comment on 'Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease'.
Inácio A; Silva AL; Morgado A; Pereira FJ; Lavinha J; Romão L
Eur J Hum Genet; 2007 May; 15(5):533-4; author reply 534. PubMed ID: 17342150
[No Abstract] [Full Text] [Related]
18. Tethering assays to investigate nonsense-mediated mRNA decay activating proteins.
Gehring NH; Hentze MW; Kulozik AE
Methods Enzymol; 2008; 448():467-82. PubMed ID: 19111190
[TBL] [Abstract][Full Text] [Related]
19. The frequent observation of evidence for nonsense-mediated decay in RNA from patients with carbamyl phosphate synthetase I deficiency.
Eeds AM; Hall LD; Yadav M; Willis A; Summar S; Putnam A; Barr F; Summar ML
Mol Genet Metab; 2006; 89(1-2):80-6. PubMed ID: 16737834
[TBL] [Abstract][Full Text] [Related]
20. Quality control of gene expression: a stepwise assembly pathway for the surveillance complex that triggers nonsense-mediated mRNA decay.
Behm-Ansmant I; Izaurralde E
Genes Dev; 2006 Feb; 20(4):391-8. PubMed ID: 16481468
[No Abstract] [Full Text] [Related]
[Next] [New Search]
